Latest News about NVO
Recent news which mentions NVO
From Motley Fool
2 Incredibly Cheap Growth Stocks to Buy Now
July 14, 2024
From Motley Fool
Is Eli Lilly a Good Dividend Stock to Buy Now?
July 14, 2024
From Motley Fool
From Motley Fool
From InvestorPlace
Did Eli Lilly Just Get a Leg Up on Novo Nordisk?
July 13, 2024
From Motley Fool
From Benzinga
3 Global Stocks Worth Buying as America Stumbles
July 12, 2024
From InvestorPlace
The 3 Most Undervalued Pharma Stocks to Buy in July 2024
July 12, 2024
From InvestorPlace
Novo Nordisk's 'Miracle' Weight Loss Drug Ozempic Linked To 48% Lower Risk Of Dementia, Study Finds
July 12, 2024
From Benzinga
From Benzinga
From Benzinga
FDA Rejects Novo Nordisk's Weekly Insulin, Requests Information Related To Manufacturing Process, Type 1 Diabetes
July 11, 2024
From Benzinga
From Benzinga
From Motley Fool
Jim Cramer Identifies Eight Companies Eyeing Trillion-Dollar Club — Elon Musk's Tesla, Eli Lilly Top Contenders
July 11, 2024
From Benzinga
3 Pharma Stocks That Could Make Your Grandchildren Rich
July 10, 2024
From InvestorPlace
Only 25% Patients Stick With Novo Nordisk's Wegovy Or Ozempic After 2 Years, A Study Shows; Company Calls Data Insufficient
July 10, 2024
From Benzinga
From InvestorPlace
From InvestorPlace
3 Stocks With the Potential to 10X Your Money
July 09, 2024
From InvestorPlace
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
July 09, 2024
From Motley Fool
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
July 09, 2024
From Benzinga
3 Overlooked Giants-in-the-Making for Patient Investors
July 08, 2024
Tags
Market News
NYSE:LLY,NYSE:NVO,NASDAQ:VKTX,NASDAQ:ARM,NYSE:CAVA,NYSE:CMG,NYSE:PFE,NASDAQ:SIRI
CAVA
From InvestorPlace
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
From Benzinga
The 7 Best Under $10 Stocks to Buy in July 2024
July 06, 2024
From InvestorPlace
GLP-1 Treatments Such As Wegvoy, Mounjaro Cut Obesity-Related Cancer Risks, Study Finds
July 05, 2024
From Benzinga
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
July 05, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.